In the latest trading session,, 1.66 million Intellia Therapeutics Inc (NASDAQ:NTLA) shares changed hands as the company’s beta touched 2.19. With the company’s most recent per share price at $8.86 changing hands around $0.36 or 4.24% at last look, the market valuation stands at $917.75M. NTLA’s current price is a discount, trading about -218.06% off its 52-week high of $28.18. The share price had its 52-week low at $5.90, which suggests the last value was 33.41% up since then.
Analysts gave the Intellia Therapeutics Inc (NTLA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.62. If we narrow down to specifics, the data shows that 0 out of 13 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended NTLA as a Hold, 13 felt it is a Buy and 0 rated the stock as Underweight.
Intellia Therapeutics Inc (NASDAQ:NTLA) trade information
Instantly NTLA is in green as seen in intraday trades today. With action 3.63%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -24.01%, with the 5-day performance at 3.63% in the green. However, in the 30-day time frame, Intellia Therapeutics Inc (NASDAQ:NTLA) is 22.54% up.
The consensus price target for the stock as assigned by Wall Street analysts is 17.5, meaning bulls need an upside of 49.37% from its recent market value. According to analyst projections, NTLA’s forecast low is 9 with 26 as the target high. To hit the forecast high, the stock’s price needs a -193.45% plunge from its current level, while the stock would need to soar -1.58% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -20.04%. The 2025 estimates are for Intellia Therapeutics Inc earnings to increase by 19.90%, but the outlook for the next 5-year period is at 27.98% per year.
NTLA Dividends
Intellia Therapeutics Inc is expected to release its next quarterly earnings report in June.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 9.897% or 9.6 million shares worth $214.79 million as of 2024-06-30.
Among Mutual Funds, the top two as of Apr 30, 2025 were ARK ETF Trust-ARK Innovation ETF and SMALLCAP WORLD FUND INC . With 8.48 shares estimated at $75.34 million under it, the former controlled 8.19% of total outstanding shares. On the other hand, SMALLCAP WORLD FUND INC held about 3.65% of the shares, roughly 3.78 shares worth around $33.56 million.
